Drugs to Watch 2024: Here are 13 potential blockbuster therapies expected to launch this year
In addition, Clarivate report highlights some new technology platforms that are likely to achieve significant proof of medical use in the market in 2024Â
Information...
MHRA approves first ‘gene-editing’ treatment for sickle-cell disease and thalassemia
It can restore healthy haemoglobin production in patients and free them from painful symptoms Â
The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised...